MedTrace Logo

Pain, Inflammation, and Cannabis in HIV

NCT04860089 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-09-22

No results posted yet for this study

Summary

This study will examine how medical cannabis use affects neuropathic pain, inflammation and adverse events in people living with HIV (PLWH) with neuropathic pain. We will study how varying ratios of THC and CBD in medical cannabis impact neuropathic pain, inflammation and adverse events.

Conditions

  • HIV Infections
  • Neuropathic Pain
  • Cannabis

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Colorado, Boulder

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • Vireo Health

    collaborator OTHER

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Deepika E Slawek, MD, MPH, MS · Montefiore Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2023-12-12
Completion
2025-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04860089 on ClinicalTrials.gov